CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,167 | $478.32 | $1.0M | 963 |
| 2025-11-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −833 | $480.44 | $400K | 130 |
| 2025-11-20 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 78,000 | ||
| 2025-11-19 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $474.22 | $948K | 2,130 |
| 2025-11-19 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $474.95 | $950K | 130 |
| 2025-11-19 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 82,000 | ||
| 2025-11-18 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $470.53 | $706K | 2,630 |
| 2025-11-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $472.60 | $473K | 1,630 |
| 2025-11-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $475.10 | $713K | 130 |
| 2025-11-18 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 86,000 | ||
| 2025-11-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $135.42 | $2.0M | 14,625 |
| 2025-11-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $470.43 | $6.9M | 0 |
| 2025-11-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +2,625 | $146.03 | $383K | 2,625 |
| 2025-11-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +5,250 | $146.03 | $767K | 7,875 |
| 2025-11-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $470.43 | $3.7M | 0 |
| 2025-11-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 12,000 | ||
| 2025-11-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −2,625 | 0 | ||
| 2025-11-17 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −5,250 | 37,690 |
Page 180 of 214 · 4,273 trades